AGF U.S. Market Neutral Anti-Beta Fund · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, AGF U.S. Market Neutral Anti-Beta Fund (BTAL) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. Average daily range 1.7%, relative volume 0.65×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | CF | 0.50% | $2M |
| 2 | MUSA | 0.50% | $2M |
| 3 | OXY | 0.48% | $2M |
| 4 | AKAM | 0.46% | $2M |
| 5 | GWRE | 0.45% | $2M |
| 6 | AR | 0.45% | $2M |
| 7 | CCC | 0.45% | $2M |
| 8 | XOM | 0.44% | $2M |
| 9 | RRC | 0.43% | $2M |
| 10 | INTU | 0.43% | $2M |
| 11 | Coterra Energy, Inc. | 0.43% | $2M |
| 12 | VeriSign, Inc. | 0.43% | $2M |
| 13 | VIRT | 0.42% | $2M |
| 14 | KR | 0.42% | $2M |
| 15 | FFIV | 0.41% | $2M |
| 16 | ADSK | 0.41% | $2M |
| 17 | NYT | 0.41% | $2M |
| 18 | VRSK | 0.41% | $2M |
| 19 | OKTA | 0.41% | $2M |
| 20 | ROP | 0.41% | $2M |
| 21 | Royalty Pharma plc | 0.41% | $2M |
| 22 | ULS | 0.41% | $2M |
| 23 | FCN | 0.41% | $2M |
| 24 | HRB | 0.40% | $2M |
| 25 | WM | 0.40% | $2M |
Showing 25 of 368 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BTAL Jan avg: -0.29% median: -1.54% win: 25% σ: 6.15% n: 4 2022-04-12 → 2026-07-31 | BTAL Feb avg: 1.26% median: -0.77% win: 25% σ: 4.28% n: 4 2022-04-12 → 2026-07-31 | BTAL Mar avg: 2.11% median: 1.27% win: 50% σ: 3.65% n: 4 2022-04-12 → 2026-07-31 | BTAL Apr avg: -0.21% median: 2.70% win: 60% σ: 6.69% n: 5 2022-04-12 → 2026-07-31 | BTAL May avg: -2.93% median: -4.98% win: 40% σ: 4.17% n: 5 2022-04-12 → 2026-07-31 | BTAL Jun avg: -1.49% median: -3.46% win: 40% σ: 6.21% n: 5 2022-04-12 → 2026-07-31 | BTAL Jul avg: -2.33% median: -4.90% win: 20% σ: 7.33% n: 5 2022-04-12 → 2026-07-31 | BTAL Aug avg: 2.03% median: 1.79% win: 50% σ: 3.22% n: 4 2022-04-12 → 2026-07-31 (current) | BTAL Sep avg: 0.70% median: 0.02% win: 50% σ: 4.22% n: 4 2022-04-12 → 2026-07-31 | BTAL Oct avg: 0.36% median: 1.57% win: 75% σ: 5.93% n: 4 2022-04-12 → 2026-07-31 | BTAL Nov avg: -2.14% median: -2.56% win: 25% σ: 3.26% n: 4 2022-04-12 → 2026-07-31 | BTAL Dec avg: -4.55% median: -2.65% win: 25% σ: 7.77% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 355 tickers across 368 holdings rows (3.5% of fund weight). Metrics as of 2026-08-24; holdings from the filing.
Holdings of BTAL currently on TickerStance stock-RS leaderboards.
| -0.30% |
| 3M RS |
| 196 |
| Stage 2 |